Cliff Asness’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Cliff Asness’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-17,400	Closed	-$141K	–	2592
2013 Q2	$141K	Buy	+17,400	New	+$129K	﹤0.01%	2259

Other funds holding TSRX

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Cliff Asness's TSRX Position: Q3 2013 in Review

Cliff Asness sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 17,400 shares — an estimated $141K sold.

Cliff Asness first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $141K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

Cliff Asness reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
Cliff Asness sold 17,400 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $141K.
Cliff Asness first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
Cliff Asness's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $141K in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on AQR Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.